Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease
- PMID: 23737748
- PMCID: PMC3667782
- DOI: 10.1371/journal.ppat.1003392
Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease
Abstract
The ability for a host to recognize infection is critical for virus clearance and often begins with induction of inflammation. The PB1-F2 of pathogenic influenza A viruses (IAV) contributes to the pathophysiology of infection, although the mechanism for this is unclear. The NLRP3-inflammasome has been implicated in IAV pathogenesis, but whether IAV virulence proteins can be activators of the complex is unknown. We investigated whether PB1-F2-mediated activation of the NLRP3-inflammasome is a mechanism contributing to overt inflammatory responses to IAV infection. We show PB1-F2 induces secretion of pyrogenic cytokine IL-1β by activating the NLRP3-inflammasome, contributing to inflammation triggered by pathogenic IAV. Compared to infection with wild-type virus, mice infected with reverse engineered PB1-F2-deficient IAV resulted in decreased IL-1β secretion and cellular recruitment to the airways. Moreover, mice exposed to PB1-F2 peptide derived from pathogenic IAV had enhanced IL-1β secretion compared to mice exposed to peptide derived from seasonal IAV. Implicating the NLRP3-inflammasome complex specifically, we show PB1-F2 derived from pathogenic IAV induced IL-1β secretion was Caspase-1-dependent in human PBMCs and NLRP3-dependent in mice. Importantly, we demonstrate PB1-F2 is incorporated into the phagolysosomal compartment, and upon acidification, induces ASC speck formation. We also show that high molecular weight aggregated PB1-F2, rather than soluble PB1-F2, induces IL-1β secretion. Furthermore, NLRP3-deficient mice exposed to PB1-F2 peptide or infected with PB1-F2 expressing IAV were unable to efficiently induce the robust inflammatory response as observed in wild-type mice. In addition to viral pore forming toxins, ion channel proteins and RNA, we demonstrate inducers of NLRP3-inflammasome activation may include disordered viral proteins, as exemplified by PB1-F2, acting as host pathogen 'danger' signals. Elucidating immunostimulatory PB1-F2 mediation of NLRP3-inflammasome activation is a major step forward in our understanding of the aetiology of disease attributable to exuberant inflammatory responses to IAV infection.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3667782/bin/ppat.1003392.g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3667782/bin/ppat.1003392.g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3667782/bin/ppat.1003392.g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3667782/bin/ppat.1003392.g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3667782/bin/ppat.1003392.g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3667782/bin/ppat.1003392.g006.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3667782/bin/ppat.1003392.g007.gif)
Similar articles
-
Identification of a short sequence motif in the influenza A virus pathogenicity factor PB1-F2 required for inhibition of human NLRP3.J Virol. 2024 May 14;98(5):e0041124. doi: 10.1128/jvi.00411-24. Epub 2024 Apr 3. J Virol. 2024. PMID: 38567952
-
PB1-F2 protein of highly pathogenic influenza A (H7N9) virus selectively suppresses RNA-induced NLRP3 inflammasome activation through inhibition of MAVS-NLRP3 interaction.J Leukoc Biol. 2020 Nov;108(5):1655-1663. doi: 10.1002/JLB.4AB0420-694R. Epub 2020 May 9. J Leukoc Biol. 2020. PMID: 32386456
-
Influenza A virus PB1-F2 protein: An ambivalent innate immune modulator and virulence factor.J Leukoc Biol. 2020 May;107(5):763-771. doi: 10.1002/JLB.4MR0320-206R. Epub 2020 Apr 23. J Leukoc Biol. 2020. PMID: 32323899 Review.
-
NS1 Protein of 2009 Pandemic Influenza A Virus Inhibits Porcine NLRP3 Inflammasome-Mediated Interleukin-1 Beta Production by Suppressing ASC Ubiquitination.J Virol. 2018 Mar 28;92(8):e00022-18. doi: 10.1128/JVI.00022-18. Print 2018 Apr 15. J Virol. 2018. PMID: 29386291 Free PMC article.
-
Hero turned villain: NLRP3 inflammasome-induced inflammation during influenza A virus infection.J Leukoc Biol. 2017 Apr;101(4):863-874. doi: 10.1189/jlb.4MR0616-288R. Epub 2016 Oct 5. J Leukoc Biol. 2017. PMID: 27707881 Review.
Cited by
-
Genomic characterization of equine influenza A subtype H3N8 viruses by long read sequencing and functional analyses of the PB1-F2 virulence factor of A/equine/Paris/1/2018.Vet Res. 2024 Mar 22;55(1):36. doi: 10.1186/s13567-024-01289-8. Vet Res. 2024. PMID: 38520035 Free PMC article.
-
The role of pyroptosis in viral infection.Arch Virol. 2024 Mar 8;169(3):69. doi: 10.1007/s00705-024-05978-9. Arch Virol. 2024. PMID: 38456965 Review.
-
The Role of the NRF2 Pathway in the Pathogenesis of Viral Respiratory Infections.Pathogens. 2023 Dec 31;13(1):39. doi: 10.3390/pathogens13010039. Pathogens. 2023. PMID: 38251346 Free PMC article. Review.
-
Regulation and functions of the NLRP3 inflammasome in RNA virus infection.Front Cell Infect Microbiol. 2024 Jan 5;13:1309128. doi: 10.3389/fcimb.2023.1309128. eCollection 2023. Front Cell Infect Microbiol. 2024. PMID: 38249297 Free PMC article. Review.
-
Phillyrin ameliorates influenza a virus-induced pulmonary inflammation by antagonizing CXCR2 and inhibiting NLRP3 inflammasome activation.Virol J. 2023 Nov 13;20(1):262. doi: 10.1186/s12985-023-02219-4. Virol J. 2023. PMID: 37957672 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous